| 标题 |
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Chloe Orkin; Enrique Bernal; Darrell H. S. Tan; Harold Katner; Hans‐Jürgen Stellbrink; et al 出版日期:2021-10-16 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)